Association analysis of hepatitis virus B infection with haplotypes of the TBX21 gene promoter region in the Chinese population

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 3, 2007, Pages 333-338

  Cao, Bangwei ^a   Yang, Hongli ^b   Ding, Howard ^c   Qi, Suxia ^b   Gao, Lei ^a   Cui, Hong ^a   Dai, Yue ^a   Xu, Changqing ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Genetic susceptibility; Haplotype; Hepatitis B virus (HBV); Promoter; TBX21 (T box21) gene

Indexed keywords

TRANSCRIPTION FACTOR T BET;

ADULT; CHINESE; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS PATHOGENESIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DNA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; T-BOX DOMAIN PROTEINS;

HEPATITIS B VIRUS;

EID: 33947610905     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.062     Document Type: Conference Paper

References (29)

1. Echevarria JM, Leon P. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica 2003;19:1583-91.
2. Lok AS. Chronic hepatitis B. N Engl J Med 2002;346:1682-3.
3. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003;9:641-4.
4. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
5. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329-39.
6. Gu CH, Luo KX. Hepatitis B, Basic biology and clinical science, 2nd ed. Beijing: People's Medical Publishing House, 2001.
7. Zhao S, Xu Z, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol 2000;29:744-52.
8. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994;17:71-91.
9. Yu MW, Chang HC, Chen PJ, Liu CJ, Liaw YF, Lin SM, et al. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan. Int J Epidemiol 2002;31:1008-15.
10. Ferrari C, Penna A, Bertoletti A, Cavalli A, Missale G, Lamonaca V, et al. Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections. Recent Results Cancer Res 1998;154:330-6.
11. Bucheton B, Abel L, Kheir MM, Mirgani A, El-Safi SH, Chevillard C, et al. Genetic control of visceral leishmaniasis in a Sudanese population, candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun 2003;4:104-9.
12. Krishnan V, Zeichner SL. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol 2004;78:9458-73.
13. Ho LJ, Shaio MF, Chang DM, Liao CL, Lai JH. Infection of human dendritic cells by dengue virus activates and primes T cells towards Th0-like phenotype producing both Th1 and Th2 cytokines. Immunol Invest 2004;33:423-37.
14. Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis 1999;19:157-69.
15. Nakamoto Y, Kaneko S. Mechanisms of viral hepatitis induced liver injury. Curr Mol Med 2003;3:537-44.
16. Ortiz GC, Sheridan JF, Marucha PT. Stress-induced changes in pathophysiology and interferon gene expression during primary HSV-1 infection. Brain Behav Immun 2003;17:329-38.
17. Sato S, Kawashima H, Oshiro H, Hasegawa D, Kashiwagi Y, Takekuma K, et al. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Virol 2004;31:235-38.
18. Qi S, Cao B, Jiang M, Xu C, Dai Y, Li K, et al. Association of the -183 polymorphism in the IFN-gamma gene promoter with hepatitis B virus infection in the Chinese population. J Clin Lab Anal 2005;19:276-81.
19. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655-69.
20. Akahoshi M, Obara K, Hirota T, Matsuda A, Hasegawa K, Takahashi N, et al. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet 2005;117:16-26.
21. Vasku A, Goldbergova M, Holla LI, Spinarova L, Spinar J, Vitovec J, et al. Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure. Clin Chem Lab Med 2003;41:1299-303.
22. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
23. Hatzakis A, Magiorkinis E, Haida C. HBV virological assessment. J Hepatol 2006;44:S71-6.
24. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4q T cells. Nat Immunol 2002;3:549-57.
25. Raby BA, Hwang ES, Van Steen K, Tantisira K, Peng S, Litonjua A, et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am J Respir Crit Care Med 2006;173:64-70.
26. Chung HT, Kim LH, Park BL, Lee JH, Park HS, Choi BW, et al. Association analysis of novel TBX21 variants with asthma phenotypes. Hum Mutat 2003;22:257-64.
27. Horton AC, Gibson-Brown JJ. Evolution of developmental functions by the Eomesodermin, T-brain-1, Tbx21 subfamily of T-box genes, insights from amphioxus. J Exp Zool 2002;294:112-21.
28. Hatton RD, Weaver CT. Immunology, T-bet or not T-bet. Science 2003;302:993-4.
29. Park HW, Lee JE, Shin ES, Lee JY, Bahn JW, Oh HB, et al. Association between genetic variations of vascular endothelial growth factor receptor 2 and atopy in the Korean population. J Allergy Clin Immunol 2006;117:774-9.